Morning After The Mega-Rally, Lilly's COVID-19 Antibody Treatment Gets FDA Emergency Approval, And An Exclusive With McDonald's CEO

<p>Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for stocks one day after the Dow, S&P 500 and Nasdaq each surged to record intraday highs. They explored the concept of buying value and selling growth -- and which stocks </p><p>went from "cheap to overvalued" during Monday's rally. The anchors also reacted to what Eli Lilly CEO David Ricks told CNBC after the FDA authorized the company's COVID-19 antibody treatment for emergency use.</p><p>In a CNBC Exclusive, McDonald's CEO Chris Kempczinski told Carl what Monday's news about Pfizer's COVID-19 vaccine candidate could mean for the fast-food giant. He also discussed the company's forthcoming plant-based burger called the "McPlant" and why he believes such products are here to stay. </p>